News
News

The latest updates from AFAR.

Industry Announcement: Board Members publish new book, “Aging: The Longevity Dividend”

Dec 22
2015

Industry Announcement: Board Members publish new book, “Aging: The Longevity Dividend”

Released in December 2015, Board Members James Kirkland, and S. Jay Olshansky and Scientific Director Emeritus George M. Martin served as editors for the new Cold Spring Harbor Laboratory Press book, Aging: The Longevity Dividend. Aging: The Longevity Dividend examines the biological basis of aging, strategies that may extend health span, and the societal implications of delayed aging.  In addition to a comprehensive examination of the biology of aging, the authors consider the socioeconomic benefits and costs of delayed aging and also outline directions for future research and translational efforts. Ten AFAR-affiliated experts have contributed essays, including: Scientific Director Steven…


View MoreREAD MORE


AFAR Receives 4-Star Charity Navigator Rating for Third Consecutive Year

Dec 22
2015

AFAR Receives 4-Star Charity Navigator Rating for Third Consecutive Year

For the third consecutive year, AFAR has received a 4-star rating for sound fiscal management and commitment to accountability and transparency from Charity Navigator, America's largest and most-utilized independent evaluator of charities. Four stars is the highest ranking granted. This rating commends AFAR for not only adhering to good governance and other best practices that minimize the chance of unethical activities but also consistently executing its mission in a fiscally responsible way.  Only 14% of the charities that Charity Navigator rats have received at least 3 consecutive 4-star evaluations, indicating that AFAR outperforms most other charities in America. Explore AFAR…


View MoreREAD MORE


AFAR in the News: Newsweek spotlights Executive Director Stephanie Lederman on  TAME study

Dec 14
2015

AFAR in the News: Newsweek spotlights Executive Director Stephanie Lederman on TAME study

On December 14, 2015 Newsweek, featured insights from AFAR Executive Director Stephanie Lederman and Deputy Scientific Director Nir Barzilai, MD’ on what the Taming Aging with Metformin (TAME) study means for pharmaceutical companies and the public. While news sources worldwide have dubbed Metformin as the “fountain of youth” that could extend human lifespan, Newsweek emphasized that TAME’s goal is extending healthspan and providing “proof of concept” for drug interventions into the biology of aging.  As Dr. Barzilai stated, the goal of the study is “to convince the FDA that aging can be targeted.…


View MoreREAD MORE


Grantees in the News: Science Magazine’s “Why We Age” Issue Features 9 AFAR-affiliated Investigators

Dec 11
2015

Grantees in the News: Science Magazine’s “Why We Age” Issue Features 9 AFAR-affiliated Investigators

For its December 4th issue Science magazine published a special “Why We Age” edition.  Featuring 9 AFAR supported investigators and board members, the issue covered a broad range of aging science topics, including aging in the animal world and reviews of newly published research. In the article “Why We Outlive Our Pets”, Scientific Director, Steven Austad, PhD, and two-time grantee Daniel Promislow, PhD, discussed theories for why longevity differs between species. In “Death-Defying Experiments” 1985 AFAR Research Grant recipient Richard Miller, MD, PhD, and 1996 AFAR Research Grant recipient, Marc Tatar, PhD, were featured in an…


View MoreREAD MORE


Board Member in the News: S. Jay Olshansky Comments on Demographic Trends

Dec 11
2015

Board Member in the News: S. Jay Olshansky Comments on Demographic Trends

On December 9th, The Province announced a new government finding that life expectancy in the US has been flat for past three years.  Board Member S. Jay Olshansky, PhD commented on the findings. While life expectancy has typically inched up each year since World War II, Dr. Olshansky does not think this finding indicates life expectancy has peaked.  He states, “It’s too early to tell, three years does not a trend make.”  The United States currently ranks 40th in the world for life expectancy.  S. Jay Olshansky, PhD, is a Professor…


View MoreREAD MORE


Board Member in the News: Scientific Director Steven Austad receives 2015 Fondation ISPEN Longevity Prize

Dec 01
2015

Board Member in the News: Scientific Director Steven Austad receives 2015 Fondation ISPEN Longevity Prize

AFAR congratulates our Scientific Director, Dr. Steven Austad, for receiving the 2015 Fondation IPSEN  Longevity Prize. Now in its 20th year, this prize is awarded to a French or international researcher--biologist, geneticist, gerontologist, psychologist, demographer, or statistician--in recognition of an outstanding contribution in the field of longevity.  Past winners include 1983 AFAR Research Grant recipient Caleb Finch. As part of the award, Dr. Austad received a €20,000 prize on November 21st, 2015 at the Gerontology Society of America (GSA) in Orlando, where he also presented a lecture entitled “Broadening the Bestiary: What a Nontraditional Species can Contribute to Understanding Aging.…


View MoreREAD MORE




BACK TO TOPBACK TO TOP